Associate Principal Scientist, Mixed Modality Product Development

The Mixed Modalities team within Sterile Product Development is responsible for developing parenteral dosage forms for small, intermediate, and large molecules from preclinical toxicology studies to commercialization. This role involves leading innovative approaches for biologics sterile product development, including experimental design, formulation, and process selection. The position requires collaboration within a multidisciplinary team to drive program milestones and support regulatory filings.